Are you Dr. Engleman?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 48 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
3373 Hillview Ave
M/C 5556
Palo Alto, CA 94304Phone+1 650-723-7960Fax+1 650-725-4470
Summary
- Dr. Edgar Engleman, MD is a pathologist in Palo Alto, California. He is currently licensed to practice medicine in California. He is affiliated with Stanford Health Care and is a Professor at Stanford University Medical Center.
Education & Training
University of California (San Francisco)Residency, Internal Medicine, 1972 - 1973
Camarillo State HospitalInternship, Internal Medicine, 1971 - 1972
Columbia University Vagelos College of Physicians and SurgeonsClass of 1971
Certifications & Licensure
CA State Medical License 1973 - 2025- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1982
Clinical Trials
- Phase I Intratumoral Dendritic Cell Immunotherapy in Thermally Ablated Liver Metastases Start of enrollment: 2004 Jan 01
- Phase I/II Intratumoral DC Immunotherapy With Gemcitabine & XRT in Unresectable Pancreatic Cancer Start of enrollment: 2005 Oct 01
- Immunostimulatory CpG SD-101 + RT in Recurrent/Progressive Lymphoma After Allogeneic Hematopoietic Cell Transplantation (HCT) Start of enrollment: 2012 Aug 01
Publications & Presentations
PubMed
- 132 citationsType I interferon responses drive intrahepatic T cells to promote metabolic syndromeMagar Ghazarian, Xavier S. Revelo, Mark K. Nøhr, Helen Luck, Kejing Zeng
Science Immunology. 2017-04-21 - 652 citationsSystemic Immunity Is Required for Effective Cancer ImmunotherapyMatthew H. Spitzer, Yaron Carmi, Nathan E. Reticker-Flynn, Serena S. Kwek, Deepthi Madhireddy
Cell. 2017-01-26 - 12 citationsCancer systems immunology.Nathan E. Reticker-Flynn, Edgar G. Engleman
Elife. 2020-07-13
Press Mentions
Cancer Cells in Lymph Nodes Crib an ‘All Access’ Pass to Metastasize, Stanford Researchers FindAugust 16th, 2022- In Memoriam: Samuel Strober, MDApril 15th, 2022
- Samuel Strober, Pioneering Transplantation Immunologist, Dies at 81March 31st, 2022
- Join now to see all
Grant Support
- Role Of Functionally Distinct Dendritic Cell Subsets In Tolerance And GVHDNational Heart, Lung, And Blood Institute2010–2011
- Immune Assay, Flow Cytometry And Gene ProfilingNational Heart, Lung, And Blood Institute2010–2011
- ImmunologyNational Cancer Institute2010–2011
- Biology And Immunology Of Pancreatic Cancer Stem Cells In A Novel Mouse ModelNational Cancer Institute2009–2011
- Prog 7- Cancer Immunology And ImmunotherapyNational Cancer Institute2007–2009
- Langerhans Cell Replacement Following Allogenic Stem Cell TransplantationNational Heart, Lung, And Blood Institute2007–2008
- Immune Assay And Flow Cytometry CoreNational Heart, Lung, And Blood Institute2007–2008
- Dendritic Cell-Nk T Cell Interactions In The SLENational Institute Of Arthritis And Musculoskeletal And Skin Diseases2004–2007
- Langerhans Cell Replacement After Stem Cell TransplantNational Heart, Lung, And Blood Institute2004–2006
- Iimmune Assay And Flow Cytometry CoreNational Heart, Lung, And Blood Institute2004–2006
- Novel Transfusion Based Immune ModulationNational Heart, Lung, And Blood Institute1997–2006
- Role Of Ctla 4 In Immune Tolerance In HumansNational Cancer Institute2001–2003
- Dendritic Cell Immunotherapy For Colorectal CancerNational Heart, Lung, And Blood Institute2002
- Core--Flow CytometryNational Heart, Lung, And Blood Institute1997–2002
- Phase I Of Flt3l Mobilized Dendritic Cell For Lung &Colon CancerNational Center For Research Resources1999–2001
- Dendritic Cell Therapy For Prostate CancerNational Center For Research Resources1998–2001
- Transfusion Based Immunotherapy For Colorectal CancerNational Heart, Lung, And Blood Institute1997–2001
- Dendritic Cell Based Vaccination For Multiple MyelomaNational Center For Research Resources1997–1999
- Use Of Altered Peptide Ligands In The Treatment Of DiabetesNational Institute Of Allergy And Infectious Diseases1996–1999
- Dendritic Cell Based Vaccination For Prostate CancerNational Cancer Institute1996–1999
- Cytotoxic T-Cell Epitopes Of Mycobacterium TuberculosisNational Institute Of Allergy And Infectious Diseases1993–1996
- Therapeutic Application &Immunology Of HIV NontargetsNational Institute Of Allergy And Infectious Diseases1994–1995
- Regulatory Lymphocytes Of The Human MLRNational Cancer Institute1993–1995
- Therapeutic Application &Immu. Of Non-Targets Of HIVNational Institute Of Allergy And Infectious Diseases1992–1993
- Suppressor T Cells Of Mixed Leukocyte Reaction In ManNational Cancer Institute1988–1992
- National Cooperative Drug Discovery Group For AIDSNational Institute Of Allergy And Infectious Diseases1987–1991
- Suppressor T Cells Of Mixed Leukocyte Reaction In ManNational Cancer Institute1985–1987
- Immunologic Defects In Lepromatous LeprosyNational Institute Of Allergy And Infectious Diseases1985–1986
- Detection Of The Carrier State Of AIDSNational Heart, Lung, And Blood Institute1985–1986
- Monoclonal Antibodies To Lymphocyte Surface MoleculesNational Institute Of Allergy And Infectious Diseases1985
- Studies Of The T-Cell Retrovirus Associated With AIDSNational Heart, Lung, And Blood Institute1985
- Immunologic StudiesNational Heart, Lung, And Blood Institute1985
- Core--Cell Sorter FacilityNational Heart, Lung, And Blood Institute1985
- Mechanism Of Impairment Of Cell-Mediated ImmunityNational Cancer Institute1985
